267 related articles for article (PubMed ID: 20922572)
1. How do tumors actively escape from host immunosurveillance?
Wilczyński JR; Duechler M
Arch Immunol Ther Exp (Warsz); 2010 Dec; 58(6):435-48. PubMed ID: 20922572
[TBL] [Abstract][Full Text] [Related]
2. How do tumor stem cells actively escape from host immunosurveillance?
Qi Y; Li RM; Kong FM; Li H; Yu JP; Ren XB
Biochem Biophys Res Commun; 2012 Apr; 420(4):699-703. PubMed ID: 22465008
[TBL] [Abstract][Full Text] [Related]
3. Tumor-host immune interactions and dendritic cell dysfunction.
Yang L; Carbone DP
Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
[TBL] [Abstract][Full Text] [Related]
4. Tumor infiltrating regulatory T cells: tractable targets for immunotherapy.
Khan AR; Dovedi SJ; Wilkinson RW; Pritchard DI
Int Rev Immunol; 2010 Oct; 29(5):461-84. PubMed ID: 20839911
[TBL] [Abstract][Full Text] [Related]
5. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer.
Gross S; Walden P
Immunol Lett; 2008 Feb; 116(1):7-14. PubMed ID: 18164076
[TBL] [Abstract][Full Text] [Related]
7. Current concepts of tumor-infiltrating lymphocytes in human malignancies.
Chiou SH; Sheu BC; Chang WC; Huang SC; Hong-Nerng H
J Reprod Immunol; 2005 Oct; 67(1-2):35-50. PubMed ID: 16111767
[TBL] [Abstract][Full Text] [Related]
8. Escape mechanisms in tumor immunity: an update.
Müller L; Kiessling R; Rees RC; Pawelec G
J Environ Pathol Toxicol Oncol; 2002; 21(4):277-330. PubMed ID: 12510961
[TBL] [Abstract][Full Text] [Related]
9. [Immune response and cancer].
El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
[TBL] [Abstract][Full Text] [Related]
10. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis.
Dirkx AE; Oude Egbrink MG; Wagstaff J; Griffioen AW
J Leukoc Biol; 2006 Dec; 80(6):1183-96. PubMed ID: 16997855
[TBL] [Abstract][Full Text] [Related]
11. A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL.
Matsui S; Ahlers JD; Vortmeyer AO; Terabe M; Tsukui T; Carbone DP; Liotta LA; Berzofsky JA
J Immunol; 1999 Jul; 163(1):184-93. PubMed ID: 10384115
[TBL] [Abstract][Full Text] [Related]
12. Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?
Salih HR; Nüssler V
Eur J Med Res; 2001 Aug; 6(8):323-32. PubMed ID: 11549514
[TBL] [Abstract][Full Text] [Related]
13. Cancer immunogene therapy.
Yoshizawa H; Kagamu H; Gejyo F
Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
[TBL] [Abstract][Full Text] [Related]
14. [Cancer immunotherapy. Importance of overcoming immune suppression].
Malvicini M; Puchulo G; Matar P; Mazzolini G
Medicina (B Aires); 2010; 70(6):565-70. PubMed ID: 21163748
[TBL] [Abstract][Full Text] [Related]
15. Capitalizing on the immunogenicity of dying tumor cells.
Fonseca C; Dranoff G
Clin Cancer Res; 2008 Mar; 14(6):1603-8. PubMed ID: 18347160
[TBL] [Abstract][Full Text] [Related]
16. Dormant tumor cells as a therapeutic target?
Quesnel B
Cancer Lett; 2008 Aug; 267(1):10-7. PubMed ID: 18384938
[TBL] [Abstract][Full Text] [Related]
17. Principles of tumor immunosurveillance and implications for immunotherapy.
Ochsenbein AF
Cancer Gene Ther; 2002 Dec; 9(12):1043-55. PubMed ID: 12522443
[TBL] [Abstract][Full Text] [Related]
18. Tumor-resident CD8+ T-cell: the critical catalyst in IL-12-mediated reversal of tumor immune suppression.
Egilmez NK; Kilinc MO
Arch Immunol Ther Exp (Warsz); 2010 Dec; 58(6):399-405. PubMed ID: 20872283
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.
ten Hagen TL; Seynhaeve AL; Eggermont AM
Immunol Rev; 2008 Apr; 222():299-315. PubMed ID: 18364010
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells.
Poggi A; Zocchi MR
Arch Immunol Ther Exp (Warsz); 2006; 54(5):323-33. PubMed ID: 17031467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
